New hope for patients struggling to breathe after major lung surgery
NCT ID NCT03409588
Summary
This study tested a drug called riociguat in 10 patients who still had trouble exercising and felt short of breath at least six months after surgery to remove old blood clots from their lungs. The goal was to see if the drug could improve their exercise capacity and breathing symptoms. Researchers measured changes in lung pressure, heart function, and walking distance over three months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC THROMBOEMBOLIC DISEASE (CTED) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado, Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.